NFKB1 and osteosarcoma: Studies have determined that aprepitant has the ability to inhibit the migrative ability of osteosarcoma tumor cells and reduce the levels of matrix metalloproteinases (MMP-2 and MMP-9), as well as NF-κB, a known stimulator of metastasis-related genes [13].